PYXS Company Profile and Key Details

Q: Who are the executives of PYXS?

Mr. John L. Flavin M.B.A., MBA, Ph.D.Co-Founder & Independent ChairmanDr. Jan Pinkas Ph.D.Chief Scientific OfficerMs. Martina Molsbergen B.S.Interim Chief Bus. OfficerDr. Lara S. Sullivan M.D., MBAChief Executive Officer, Pres & DirectorDr. Jay M. Feingold M.D., Ph.D.Chief Medical OfficerDr. Charles T. Gombar Ph.D.Senior Vice President of Portfolio & Program ManagementMr. Jitendra WadhaneChief Accounting Officer, Senior Vice President of Fin. & Corporation ControllerMs. Pamela Yanchik Connealy M.B.A.Chief Financial Officer & Chief Operating OfficerDr. Balu N. Balasubramanian Ph.D.Advisor

NASDAQ : PYXS

Pyxis Oncology

$1.15

0.06+5.50%

At Close 4:00 PM

55.38

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Pyxis Oncology, Inc. (PYXS) stock surged +5.50%, trading at $1.15 on NASDAQ, up from the previous close of $1.09. The stock opened at $1.11, fluctuating between $1.09 and $1.20 in the recent session.

Stock Snapshot

1.09

Prev. Close

71.59M

Market Cap

1.085

Day Low

-0.73

P/E Ratio

-1.58

EPS (TTM)

-1.73

Cash Flow per Share

1.11

Open

62.25M

Number of Shares

1.2

Day High

65.8%

Free Float in %

2.81

Book Value

1.55M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Dec 31, 2025	1.12	1.20	1.09	1.15	1.58M
Dec 30, 2025	1.06	1.18	1.06	1.09	2.44M
Dec 29, 2025	1.11	1.15	1.04	1.06	1.71M
Dec 26, 2025	1.13	1.15	1.03	1.11	1.61M
Dec 24, 2025	1.10	1.16	1.08	1.11	1.42M
Dec 23, 2025	1.19	1.26	1.05	1.09	2.58M
Dec 22, 2025	1.31	1.39	1.16	1.19	3.09M
Dec 19, 2025	1.75	1.80	1.23	1.27	5.29M
Dec 17, 2025	4.01	4.03	3.35	3.37	843.78K
Dec 16, 2025	4.17	4.17	3.85	4.00	413.7K
Dec 15, 2025	4.30	4.49	4.18	4.20	206.52K
Dec 12, 2025	4.40	4.58	4.25	4.30	340K
Dec 11, 2025	4.28	4.42	4.17	4.41	334.59K
Dec 10, 2025	4.30	4.34	4.10	4.29	280.58K
Dec 09, 2025	4.16	4.35	4.12	4.30	288.51K
Dec 08, 2025	4.21	4.30	4.11	4.18	474.01K
Dec 05, 2025	4.34	4.42	4.18	4.22	417.87K
Dec 04, 2025	4.52	4.59	4.25	4.32	850.06K
Dec 03, 2025	3.82	4.61	3.81	4.60	1.19M
Dec 02, 2025	4.37	4.39	3.67	3.91	1.74M

Contact Details

Boston, MA 02140

United States

https://www.pyxisoncology.com 617 221 9059

About Company

Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, non-small cell lung cancer (NSCLC), and other solid tumors; and PYX-102, an investigational immune-therapeutic for treatment of solid tumors. The company's antibody drug conjugate (ADC) product candidates comprise of PYX-201, an investigational novel ADC to treat NSCLC, breast cancer, and other solid tumors; PYX-202, an investigational novel ADC for treatment of SCLC, soft tissue sarcoma, and other solid tumors; and PYX-203, an investigational ADC for the treatment of acute myeloid leukemia and myeloid dysplastic syndrome. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.

Stock Peers

ARGX

3.05+0.36%

argenx SE$840.95 REGN

-2.07-0.27%

Regeneron Pharmaceuticals, Inc.$771.87 MDGL

-1.39-0.24%

Madrigal Pharmaceuticals, Inc.$582.34 UTHR

-8.94-1.80%

United Therapeutics Corporation$487.25 VRTX

-0.38-0.08%

Vertex Pharmaceuticals Incorporated$453.36 ALNY

0.4+0.10%

Alnylam Pharmaceuticals, Inc.$397.65 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-2.28-0.77%

Praxis Precision Medicines, Inc.$294.74 KRYS

-1.34-0.54%

Krystal Biotech, Inc.$246.54 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current Pyxis Oncology, Inc. (PYXS) stock price?

Pyxis Oncology, Inc. (NASDAQ: PYXS) stock price is $1.15 in the last trading session. During the trading session, PYXS stock reached the peak price of $1.20 while $1.09 was the lowest point it dropped to. The percentage change in PYXS stock occurred in the recent session was 5.5% while the dollar amount for the price change in PYXS stock was $0.06.

PYXS's industry and sector of operation?

The NASDAQ listed PYXS is part of Biotechnology industry that operates in the broader Healthcare sector. Pyxis Oncology, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of PYXS?

Mr. John L. Flavin M.B.A., MBA, Ph.D.
Co-Founder & Independent Chairman
Dr. Jan Pinkas Ph.D.
Chief Scientific Officer
Ms. Martina Molsbergen B.S.
Interim Chief Bus. Officer
Dr. Lara S. Sullivan M.D., MBA
Chief Executive Officer, Pres & Director
Dr. Jay M. Feingold M.D., Ph.D.
Chief Medical Officer
Dr. Charles T. Gombar Ph.D.
Senior Vice President of Portfolio & Program Management
Mr. Jitendra Wadhane
Chief Accounting Officer, Senior Vice President of Fin. & Corporation Controller
Ms. Pamela Yanchik Connealy M.B.A.
Chief Financial Officer & Chief Operating Officer
Dr. Balu N. Balasubramanian Ph.D.
Advisor

How PYXS did perform over past 52-week?

PYXS's closing price is 38.05% higher than its 52-week low of $0.83 where as its distance from 52-week high of $5.55 is -79.28%.

How many employees does PYXS have?

Number of PYXS employees currently stands at 44.

Link for PYXS official website?

Official Website of PYXS is: https://www.pyxisoncology.com

How do I contact PYXS?

PYXS could be contacted at phone 617 221 9059 and can also be accessed through its website. PYXS operates from 35 Cambridgepark Drive, Boston, MA 02140, United States.

How many shares of PYXS are traded daily?

PYXS stock volume for the day was 1.55M shares. The average number of PYXS shares traded daily for last 3 months was 1.14M.

What is the market cap of PYXS currently?

The market value of PYXS currently stands at $71.59M with its latest stock price at $1.15 and 62.25M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	44
Beta	1.38
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	44
Beta	1.38
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

PYXS Company Profile and Key Details

Pyxis Oncology

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Valuation Metrics

Technical Performance

Company Overview

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways